TargetMol

Trimopam

Product Code:
 
TAR-T34951
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T34951-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34951-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34951-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Trimopam is a dopamine receptor agonist of the benzazepine group.
CAS:
20012-08-2
Formula:
C19H23NO2
Molecular Weight:
297.398
Purity:
0.98
SMILES:
COc1cc2CCN(C)CC(c3ccccc3)c2cc1OC

References

Breese GR, Criswell HE, McQuade RD, Iorio LC, Mueller RA. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. J Pharmacol Exp Ther. 1990 Feb;252(2):558-67. Erratum in: J Pharmacol Exp Ther 1990 Oct;255(1):401. PubMed PMID: 1968972. Winter JC. Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus. Psychopharmacology (Berl). 1980;68(2):159-62. PubMed PMID: 6776559. Olivier B, van Aken H, Jaarsma I, van Oorschot R, Zethof T, Bradford D. Behavioural effects of psychoactive drugs on agonistic behaviour of male territorial rats (resident-intruder model). Prog Clin Biol Res. 1984;167:137-56. PubMed PMID: 6095317. Breese GR, Criswell HE, Mueller RA. Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14 Suppl:S65-80. Review. PubMed PMID: 1982973.